Alberto García‐Lledó

Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention

Vincent Roolvink, Borja Ibáñez, Jan Paul Ottervanger et al. · Journal of the American College of Cardiology · 2016 · 199 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Endothelial dysfunction, intima–media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis

Raquel Campuzano, José Luis Betrán Moya, Alberto García‐Lledó et al. · Journal of Hypertension · 2006 · 61 citations

Predictors of persistent pulmonary hypertension after mitral valve replacement

S Briongos Figuero, José Luis Moya Mur, Alberto García‐Lledó et al. · Heart and Vessels · 2015 · 35 citations

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +7

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 32 citations · Full text